Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Urinary Bladder Neoplasms
×
infigratinib
×
Clear all
Filters
3
NCT04972253
2022-08-10
(BLASST)-3
Dana-Farber Cancer Institute
Phase 1
Withdrawn